P716 Beta-blocker use is associated with a higher relapse risk of inflammatory bowel disease – a Dutch retrospective cohort study

Authors :: Maria Pippias
Tinka Bakker
Rose Willemze
C.Y. Ponsioen
W J de Jonge
Source :: Journal of Crohn's and Colitis. 11:S447-S447
Publication Year :: 2017
Publisher :: Oxford University Press (OUP), 2017.

Subjects :: medicine.medical_specialty
medicine.drug_class
business.industry
Internal medicine
Gastroenterology
medicine
Retrospective cohort study
General Medicine
Relapse risk
medicine.disease
business
Beta blocker
Inflammatory bowel disease

Full Text Access

Tools